Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 602S-610S

  Stein, Paul D ^a   Alpert, Joseph S ^a   Dalen, James E ^a   Horstkotte, Dieter ^a   Turpie, Alexander G G ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN ANTICOAGULANT; DIPYRIDAMOLE; WARFARIN;

ANTICOAGULATION; BIOPROSTHESIS; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; HEART VALVE PROSTHESIS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

EID: 0031789424     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.602S     Document Type: Conference Paper

References (10)

1. Stein PD, Alpert JS, Copeland J, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995; 108(suppl):371S-379S
2. Turpie AGG, Gent M, Laupacis A, et al. Comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329:524-529
3. Stein PD, Grandison D, Hua TA, et al. Therapeutic levels of oral anticoagulation with warfarin in patients with mechanical prosthetic heart valves: review of literature and recommendations based on international normalized ratio. Postgrad Med J 1994; 70(suppl 1):S72-S83
4. Stein PD, Alpert JS, Copeland J, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992; 102(suppl):445S-455S
5. Horstkotte D, Schulte HD, Bircks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude medical prosthesis. J Thorac Cardiovasc Surg 1994; 107:1136-1145
6. Rodler SM, Moritz A, Schreiner W, et al. Five-year follow-up after heart valve replacement with the CarboMedics bileaflet prosthesis. Ann Thorac Surg 1997; 63:1018-1025
7. Baudet EM, Oca CC, Roques XF, et al. A 5 1/2 year experience with the St. Jude medical cardiac valve prosthesis: early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985; 90:137-144
8. Vogt S, Hoffmann A, Roth J, et al. Heart valve replacement with the Björk-Shiley and St. Jude medical prostheses: a randomized comparison in 178 patients. Eur Heart J 1990; 11:583-591
9. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996; 94:2107-2112
10. Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anti-coagulation after complete 10 year follow-up of patients with St. Jude medical prostheses. J Heart Valve Dis 1993; 2:291-301